Comparison of Pulmicort pMDI plus Nebuhaler and Pulmicort Turbuhaler in asthmatic patients with dysphonia.

@article{Crompton2000ComparisonOP,
  title={Comparison of Pulmicort pMDI plus Nebuhaler and Pulmicort Turbuhaler in asthmatic patients with dysphonia.},
  author={Graham K. Crompton and Rob Sanderson and M. Dewar and Simon Matusiewicz and A C Ning and A H Jamieson and A. D. McLean and Andrew P. Greening},
  journal={Respiratory medicine},
  year={2000},
  volume={94 5},
  pages={
          448-53
        }
}
BACKGROUND Dysphonia is a known local adverse effect of inhaled corticosteroids. This symptom was investigated by laryngoscopy and assessment in a voice laboratory. The effects of changing the treatment of patients with dysphonia, reported whilst using the pMDI, to pMDI plus Nebuhaler or Tubuhaler was also assessed. METHODS Seventy-two patients reporting dysphonia and taking inhaled steroids from a pMDI entered a 12-week, open, parallel group study. Fifty-one completed the study per protocol… CONTINUE READING